The top 10 pipeline blowups, set­backs and sna­fus for H1 2021

Once the pan­dem­ic hit, it was in­stant­ly clear that the in­dus­try was go­ing to cre­ate an en­tire pipeline of vac­cines and new drugs to fight back against Covid-19. In do­ing so, it al­so be­came in­stant­ly clear that we were go­ing to get a crash course on just how bad things can go.

In the back­drop to some spec­tac­u­lar suc­cess­es, we saw some of the biggest play­ers in bio­phar­ma stum­ble, fall and in some cas­es nev­er get back up again. You can find some of the most sig­nif­i­cant set­backs in the list be­low.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN